We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Clinical trials were approved for recombinant human papillomavirus 9-valent vaccine (Pichia pastoris) and recombinant herpes zoster vaccine (CHO) jointly applied for by Shanghai Easyway and Ab&b Bio-Tech on July 27.